HUMANIGEN INC (HGEN)
US4448632038 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to HGEN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.15. This target is 323.82% above the current price.
HGEN was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about HGEN.
In the previous month the buy percentage consensus was at a similar level.
HGEN was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-04-03 | Credit Suisse | Reiterate | Underperform |
| 2023-01-11 | Cantor Fitzgerald | Reiterate | Neutral |
| 2022-07-13 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-07-13 | Roth Capital | Downgrade | Buy -> Neutral |
| 2022-07-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-09-10 | Jefferies | Downgrade | Buy -> Hold |
| 2021-09-09 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-09-09 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-13 | Credit Suisse | Maintains | Outperform |
| 2021-08-10 | Roth Capital | Maintains | Buy |
| 2021-06-11 | Credit Suisse | Initiate | Outperform |
| 2021-05-07 | Oppenheimer | Initiate | Outperform |
| 2021-04-12 | HC Wainwright & Co. | Reiterate | Buy |